Cargando…

Quality of life and voice outcome of patients treated with transoral CO(2) laser microsurgery for early glottic carcinoma (T1–T2): a 2-year follow-up study

PURPOSE: Longitudinal studies in laryngeal cancer can provide clinicians information about short-term and long-term functional outcomes, like quality of life (QoL) and voice outcome. This information is important when counseling patients or choosing a primary treatment modality. The present study as...

Descripción completa

Detalles Bibliográficos
Autores principales: Hendriksma, Martine, van Loon, Yda, Klop, W. Martin C., Hakkesteegt, Marieke M., Heijnen, Bas J., el Hasnaoui, Ibtissam, de Jong, Martin, Langeveld, Ton P. M., van Benthem, Peter Paul G., Baatenburg de Jong, Robert J., Sjögren, Elisabeth V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411677/
https://www.ncbi.nlm.nih.gov/pubmed/30810819
http://dx.doi.org/10.1007/s00405-019-05348-1
_version_ 1783402428711829504
author Hendriksma, Martine
van Loon, Yda
Klop, W. Martin C.
Hakkesteegt, Marieke M.
Heijnen, Bas J.
el Hasnaoui, Ibtissam
de Jong, Martin
Langeveld, Ton P. M.
van Benthem, Peter Paul G.
Baatenburg de Jong, Robert J.
Sjögren, Elisabeth V.
author_facet Hendriksma, Martine
van Loon, Yda
Klop, W. Martin C.
Hakkesteegt, Marieke M.
Heijnen, Bas J.
el Hasnaoui, Ibtissam
de Jong, Martin
Langeveld, Ton P. M.
van Benthem, Peter Paul G.
Baatenburg de Jong, Robert J.
Sjögren, Elisabeth V.
author_sort Hendriksma, Martine
collection PubMed
description PURPOSE: Longitudinal studies in laryngeal cancer can provide clinicians information about short-term and long-term functional outcomes, like quality of life (QoL) and voice outcome. This information is important when counseling patients or choosing a primary treatment modality. The present study assessed long-term (2 years) QoL and voice outcome in patients with extended T1 and limited T2 glottic carcinoma treated with transoral CO(2) laser microsurgery (TLM) (unilateral type III or bilateral type II resections). METHODS: Three questionnaires were administered: the Voice Handicap Index (VHI), the European Organization for Research and Treatment of Cancer (EORTC) QoL questionnaire (QLQ)-C30, the EORTC QLQ-HN35. A perceptual voice evaluation at six different time points was conducted: preoperatively, and postoperatively at 6 weeks, 3 months, 6 months, 1 year, and 2 years. Fluctuations over time were investigated. RESULTS: Sixty-one patients were included in the analysis. Patients reported high-level functioning and low symptom scores 2 years postoperatively. Gender significantly affected the VHI scores at 2 years (mean VHI scores: female 8.7 vs. male, 23.9; p = 0.023). The major improvement in VHI scores was observed within the first 6 months. The tumor stage (T1a, T1b, and T2) significantly impacted the grade (mean scores at 2 years: 1.0, 1.9, and 1.7; p = 0.001). These scores stabilized at 6 months. CONCLUSIONS: Patients show good long-term QoL with low symptom scores, a low voice handicap, and mild to moderate dysphonia, 2 years postoperatively. Scores stabilize at 6 months and provide a clear indication of status at 1 and 2 years.
format Online
Article
Text
id pubmed-6411677
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-64116772019-04-03 Quality of life and voice outcome of patients treated with transoral CO(2) laser microsurgery for early glottic carcinoma (T1–T2): a 2-year follow-up study Hendriksma, Martine van Loon, Yda Klop, W. Martin C. Hakkesteegt, Marieke M. Heijnen, Bas J. el Hasnaoui, Ibtissam de Jong, Martin Langeveld, Ton P. M. van Benthem, Peter Paul G. Baatenburg de Jong, Robert J. Sjögren, Elisabeth V. Eur Arch Otorhinolaryngol Laryngology PURPOSE: Longitudinal studies in laryngeal cancer can provide clinicians information about short-term and long-term functional outcomes, like quality of life (QoL) and voice outcome. This information is important when counseling patients or choosing a primary treatment modality. The present study assessed long-term (2 years) QoL and voice outcome in patients with extended T1 and limited T2 glottic carcinoma treated with transoral CO(2) laser microsurgery (TLM) (unilateral type III or bilateral type II resections). METHODS: Three questionnaires were administered: the Voice Handicap Index (VHI), the European Organization for Research and Treatment of Cancer (EORTC) QoL questionnaire (QLQ)-C30, the EORTC QLQ-HN35. A perceptual voice evaluation at six different time points was conducted: preoperatively, and postoperatively at 6 weeks, 3 months, 6 months, 1 year, and 2 years. Fluctuations over time were investigated. RESULTS: Sixty-one patients were included in the analysis. Patients reported high-level functioning and low symptom scores 2 years postoperatively. Gender significantly affected the VHI scores at 2 years (mean VHI scores: female 8.7 vs. male, 23.9; p = 0.023). The major improvement in VHI scores was observed within the first 6 months. The tumor stage (T1a, T1b, and T2) significantly impacted the grade (mean scores at 2 years: 1.0, 1.9, and 1.7; p = 0.001). These scores stabilized at 6 months. CONCLUSIONS: Patients show good long-term QoL with low symptom scores, a low voice handicap, and mild to moderate dysphonia, 2 years postoperatively. Scores stabilize at 6 months and provide a clear indication of status at 1 and 2 years. Springer Berlin Heidelberg 2019-02-27 2019 /pmc/articles/PMC6411677/ /pubmed/30810819 http://dx.doi.org/10.1007/s00405-019-05348-1 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Laryngology
Hendriksma, Martine
van Loon, Yda
Klop, W. Martin C.
Hakkesteegt, Marieke M.
Heijnen, Bas J.
el Hasnaoui, Ibtissam
de Jong, Martin
Langeveld, Ton P. M.
van Benthem, Peter Paul G.
Baatenburg de Jong, Robert J.
Sjögren, Elisabeth V.
Quality of life and voice outcome of patients treated with transoral CO(2) laser microsurgery for early glottic carcinoma (T1–T2): a 2-year follow-up study
title Quality of life and voice outcome of patients treated with transoral CO(2) laser microsurgery for early glottic carcinoma (T1–T2): a 2-year follow-up study
title_full Quality of life and voice outcome of patients treated with transoral CO(2) laser microsurgery for early glottic carcinoma (T1–T2): a 2-year follow-up study
title_fullStr Quality of life and voice outcome of patients treated with transoral CO(2) laser microsurgery for early glottic carcinoma (T1–T2): a 2-year follow-up study
title_full_unstemmed Quality of life and voice outcome of patients treated with transoral CO(2) laser microsurgery for early glottic carcinoma (T1–T2): a 2-year follow-up study
title_short Quality of life and voice outcome of patients treated with transoral CO(2) laser microsurgery for early glottic carcinoma (T1–T2): a 2-year follow-up study
title_sort quality of life and voice outcome of patients treated with transoral co(2) laser microsurgery for early glottic carcinoma (t1–t2): a 2-year follow-up study
topic Laryngology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411677/
https://www.ncbi.nlm.nih.gov/pubmed/30810819
http://dx.doi.org/10.1007/s00405-019-05348-1
work_keys_str_mv AT hendriksmamartine qualityoflifeandvoiceoutcomeofpatientstreatedwithtransoralco2lasermicrosurgeryforearlyglotticcarcinomat1t2a2yearfollowupstudy
AT vanloonyda qualityoflifeandvoiceoutcomeofpatientstreatedwithtransoralco2lasermicrosurgeryforearlyglotticcarcinomat1t2a2yearfollowupstudy
AT klopwmartinc qualityoflifeandvoiceoutcomeofpatientstreatedwithtransoralco2lasermicrosurgeryforearlyglotticcarcinomat1t2a2yearfollowupstudy
AT hakkesteegtmariekem qualityoflifeandvoiceoutcomeofpatientstreatedwithtransoralco2lasermicrosurgeryforearlyglotticcarcinomat1t2a2yearfollowupstudy
AT heijnenbasj qualityoflifeandvoiceoutcomeofpatientstreatedwithtransoralco2lasermicrosurgeryforearlyglotticcarcinomat1t2a2yearfollowupstudy
AT elhasnaouiibtissam qualityoflifeandvoiceoutcomeofpatientstreatedwithtransoralco2lasermicrosurgeryforearlyglotticcarcinomat1t2a2yearfollowupstudy
AT dejongmartin qualityoflifeandvoiceoutcomeofpatientstreatedwithtransoralco2lasermicrosurgeryforearlyglotticcarcinomat1t2a2yearfollowupstudy
AT langeveldtonpm qualityoflifeandvoiceoutcomeofpatientstreatedwithtransoralco2lasermicrosurgeryforearlyglotticcarcinomat1t2a2yearfollowupstudy
AT vanbenthempeterpaulg qualityoflifeandvoiceoutcomeofpatientstreatedwithtransoralco2lasermicrosurgeryforearlyglotticcarcinomat1t2a2yearfollowupstudy
AT baatenburgdejongrobertj qualityoflifeandvoiceoutcomeofpatientstreatedwithtransoralco2lasermicrosurgeryforearlyglotticcarcinomat1t2a2yearfollowupstudy
AT sjogrenelisabethv qualityoflifeandvoiceoutcomeofpatientstreatedwithtransoralco2lasermicrosurgeryforearlyglotticcarcinomat1t2a2yearfollowupstudy